Ledger.Open graph →

SEC Form D · filed April 16, 2020

GVB Biopharma

Offering

$2.0M

Sold

$450K

Exemption

Rule 506(b)

Industry

Manufacturing

Location

LAS VEGAS, NV

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

William Spiegel · Las Vegas, NVExec · Director Phillip Swindells · Las Vegas, NVExec · Director Theodore Swindells · Las Vegas, NVDirector Jack Feldman · Las Vegas, NVExec · Director Chester S. Zygmont Iii · San Diego, CADirector Scott Craven Jones · Kenilworth, ILExec · Director Eric Chen · Los Altos, CAExec · Director John J. D'Agostino · New York, NYExec · Director Todd Davis · Newport Beach, CAExec · Director Doug Weekes · Newport Beach, CAExec · Director Ben Mandell · Miami, FLExec · Director Scott Sherman · Miami, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗